IL6R and neoplasm: Our data also showed that Fc-VFD combined with Actemra (tocilizumab, anti-IL6R) or Avastin (Bevacizumab, anti-VEGF-A) are successful therapeutic strategies to normalize intratumor vessels and inhibit tumor growth.